Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: A controlled, 12-month randomized trial

British Journal of Dermatology

Volumn 146, Issue 6, 2002, Pages 992-999

  Vexiau, P ^a   Chaspoux, C ^a   Boudou, P ^a   Fiet, J ^a   Jouanique, C ^a   Hardy, N ^a   Reygagne, P ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Cyproterone acetate; Female androgenetic alopecia; Minoxidil

Indexed keywords

CYPROTERONE ACETATE; DIANE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; MINOXIDIL;

ACNE; ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HAIR; HIRSUTISM; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MALE TYPE ALOPECIA; MENSTRUAL CYCLE; PRIORITY JOURNAL; SCALP; SEBORRHEA; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; ALOPECIA; ANDROGEN ANTAGONISTS; BODY MASS INDEX; CONTRACEPTIVES, ORAL, COMBINED; CYPROTERONE ACETATE; DERMATITIS, SEBORRHEIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPERANDROGENISM; MINOXIDIL;

EID: 0036067176     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04798.x     Document Type: Article

References (25)

1. Female androgenic alopecia. The 3,17β-androstanediol glucuronide/sex hormone binding globulin ratios as possible markers for female baldness
2. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution
3. Three percent topical minoxidil therapy for female androgenetic alopecia
4. Use of topical minoxidil therapy for androgenetic alopecia in women
5. Topical minoxidil in the treatment of androgenetic alopecia in women
6. Quantitative estimation of hair growth. I. Androgenetic alopecia in women: Effect of minoxidil
7. Treatment of female androgenetic alopecia with minoxidil 2%
8. Oral antiandrogen treatment of common baldness in women
9. Treatment of hirsutism, acne and alopecia with cyproterone acetate
10. Effective medical treatment of common baldness in women
11. Cyproterone acetate ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia
12. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females
13. Etiology and diagnosis of androgenetic alopecia
14. Aetiology and pathophysiology of hair loss
15. Profil hormonal de 56 femmes atteintes d'alopecie dite androgenetique
16. Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism
17. Obesity and female androgenic alopecia: A cause and an effect?
18. Dehydroepiandrosterone dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and non-insulin-dependent diabetes in postmenopausal women: The Rancho Bernardo study
19. Clinical utility of sex hormone-binding globulin measurement
20. Classification of the types of androgenic alopecia
21. Biochemical and trichological characterization of diffuse alopecia in women
22. Scalp immersion proxigraphy (SIP): An improved imaging technique for phototrichogram analysis
23. The therapeutic use of topical minoxidil
24. Etude comparative d'un nouveau traitement dans l'alopécie androgénique masculine. Essai randomisé versus minoxidil à 2%
25. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism